Muscle News and Research

RSS

Autoimmune antibodies strongly linked to the severity of illness in COVID-19 patients

The presence of special immune system defense molecules, called autoimmune antibodies, has been strongly tied to how poorly people fare when hospitalized with COVID-19, a new study shows.

9 Sep 2021

Discovery about cellular 'batteries' could open the door to better treatments for many diseases

A top exercise researcher at the University of Virginia School of Medicine has revealed how our bodies ensure the proper functioning of the powerhouses of our cells.

9 Sep 2021

Neuropsychiatric symptoms in children and adolescents with long COVID

In a recent study, researchers determine the presence of any neuropsychological symptoms after recovering from COVID-19 in children and adolescents.

8 Sep 2021

Study finds no serious side effects of mRNA COVID-19 vaccines in lactating women, breastfed infants

In December 2020, two novel messenger RNA (mRNA) vaccines for SARS-CoV-2 received emergency use authorization from the U.S. Food and Drug Administration; however, the early trials excluded lactating women, leading to questions about their safety in this specific population.

8 Sep 2021

German study finds lack of association between SARS-CoV-2 infection and neuroaxonal damage

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the virus that causes coronavirus disease 2019 (COVID-19) – is not associated with neuroaxonal damage, according to a new study from researchers in Germany.

8 Sep 2021

People living with HIV have higher risk of sudden cardiac death, finds study

People living with human immunodeficiency virus (HIV) have a higher risk of sudden cardiac death than people who do not have HIV, especially if the virus is not well-controlled or if they have other heart disease risk factors.

8 Sep 2021

Using infodemiology to understand symptoms of SARS-CoV-2 Lambda variant

A new variant (lineage C.37) initially identified in Lima, Peru, has since been classified as “Lambda” by the World Health Organization (WHO). The lambda variant was classified in June 2021 by the WHO as a “variant of interest.”

6 Sep 2021

Researchers develop the smallest CRISPR to date for genome editing

A compact and efficient CRISPR-Cas system, named CasMINI, could be broadly useful for cell-engineering and gene-therapy applications because it is easier to deliver into cells. The findings appear in a study publishing September 3 in the journal Molecular Cell.

4 Sep 2021

Risk of COVID-19 transmission from animals to older adults

A new study in the journal GeroScience deals with this aspect of the disease, especially with respect to preventing higher death rates in older adults.

2 Sep 2021

Regional differences in prevalence of SARS-CoV-2 antibodies in children

A population-based study assesses seroprevalence in a representative sample of children from regions with high and low community transmission.

2 Sep 2021

CHOP researchers develop tool to monitor disease severity in patients with mitochondrial myopathy

Researchers at Children's Hospital of Philadelphia successfully developed and validated a new outcome measure to monitor disease severity and progression in patients with impaired skeletal muscle function caused by mitochondrial disease.

1 Sep 2021

Green tea extract and cocoa-supplemented diets improve survival rate of aging mice

Aging-US published "Beneficial effects of dietary supplementation with green tea catechins and cocoa flavanols on aging-related regressive changes in the mouse neuromuscular system" which reported that green tea extract (GTE) and cocoa-supplemented diets significantly improved the survival rate of mice.

1 Sep 2021

New AI technology for heart imaging could improve care for patients

A new artificial-intelligence technology for heart imaging can potentially improve care for patients, allowing doctors to examine their hearts for scar tissue while eliminating the need for contrast injections required for traditional cardiovascular magnetic resonance imaging (CMR).

1 Sep 2021

Studies outlines novel strategies for detecting cancer and minimal residual disease

The latest special issue of PLOS Medicine features five studies outlining novel strategies for detecting cancer and for identifying minimal residual disease - when a small number of tumor cells survive treatment, potentially leading to recurrence of cancer.

1 Sep 2021

European study sheds light on the burden of Parkinson’s disease in patients and their carers

Results of a new European study published in the Journal of Parkinson's Disease may help improve clinical practice by shedding light on the lives of people with PD and their carers, re-emphasizing the many challenges they face in everyday life.

31 Aug 2021

Liquid biopsies could help identify, track bladder cancer and peripheral nerve tumors

Liquid biopsies detect tumor DNA in blood or urine samples. Two studies led by Washington University School of Medicine in St. Louis describe the potential of liquid biopsies to identify and track tumor growth in two very different cancers: bladder cancer and peripheral nerve tumors.

31 Aug 2021

Abdominal fat and weak muscles associated with loss of gait speed in older people

Weak muscles and abdominal fat are a dangerous combination for older people who have difficulty walking.

31 Aug 2021

Researchers identify biomarkers for rare, serious complication in children with COVID-19

The study focused on multisystem inflammatory syndrome in children (MIS-C), an inflammatory response involving multiple organs that can occur weeks after infection with SARS-CoV-2, the virus that causes COVID-19.

31 Aug 2021

Genomic autopsy reveals many genetic variants associated with cardiomyopathy

Postmortem genetic testing, or genomic autopsy, of young individuals who experienced sudden death revealed many had known genetic variants that are associated with cardiomyopathy, according to a Northwestern Medicine study published in JAMA Cardiology.

31 Aug 2021

The tale of mRNA vaccines: Turning calamity into opportunity

In a review paper published in the journal Nature Reviews, researchers from Carnegie Mellon University and the University of Pennsylvania have described the underlying technologies for mRNA vaccines and their future prospects with improved delivery systems and applications in diseases beyond the ongoing COVID-19 pandemic.

31 Aug 2021

Muscle News and Research

Autoimmune antibodies strongly linked to the severity of illness in COVID-19 patients

Discovery about cellular 'batteries' could open the door to better treatments for many diseases

Neuropsychiatric symptoms in children and adolescents with long COVID

Study finds no serious side effects of mRNA COVID-19 vaccines in lactating women, breastfed infants

German study finds lack of association between SARS-CoV-2 infection and neuroaxonal damage

People living with HIV have higher risk of sudden cardiac death, finds study

Using infodemiology to understand symptoms of SARS-CoV-2 Lambda variant

Researchers develop the smallest CRISPR to date for genome editing

Risk of COVID-19 transmission from animals to older adults

Regional differences in prevalence of SARS-CoV-2 antibodies in children

CHOP researchers develop tool to monitor disease severity in patients with mitochondrial myopathy

Green tea extract and cocoa-supplemented diets improve survival rate of aging mice

New AI technology for heart imaging could improve care for patients

Studies outlines novel strategies for detecting cancer and minimal residual disease

European study sheds light on the burden of Parkinson’s disease in patients and their carers

Liquid biopsies could help identify, track bladder cancer and peripheral nerve tumors

Abdominal fat and weak muscles associated with loss of gait speed in older people

Researchers identify biomarkers for rare, serious complication in children with COVID-19

Genomic autopsy reveals many genetic variants associated with cardiomyopathy

The tale of mRNA vaccines: Turning calamity into opportunity

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News